My area of interest is in clinical epidemiology and natural history of disease and patterns of health service delivery. Within those core areas, I have also been involved in research aimed at the optimal use of evidence based treatments and practice/policy improvement.
My area of interest is in clinical epidemiology and natural history of disease and patterns of health service delivery. Within those core areas, I have also been involved in research aimed at the optimal use of evidence based treatments and practice/policy improvement.
Currently, my main focus is on pharmacoepidemiological studies evaluating the impact of drug therapies on morbidity and mortality in patients with type 2 diabetes. In a secondary area of research, I am actively involved in numerous health outcome research projects in people with community acquired pneumonia.
Given the nature of my research, most of my studies involve the use of advanced biostatistical techniques. This includes the use of time-dependent survival analysis, nested case control designs, propensity scores, and matching techniques.